Literature DB >> 35505940

Optimizing Immunization Strategies in Adult Patients With Chronic Liver Disease and Liver Transplant Recipients.

Stacey Rolak1, Adnan Said2, Rita German2, Mary S Hayney3, Freddy Caldera2.   

Abstract

Patients with chronic liver disease (CLD) and liver transplant recipients are at increased risk for infections from vaccine-preventable diseases. Gastroenterologists and hepatologists should assess patient immunization history, and necessary vaccinations should be given as soon as possible. Vaccines demonstrate superior immunogenicity when given earlier in the course of liver disease and prior to transplant. This article summarizes recommendations from the Advisory Committee on Immunization Practices for vaccinations in patients with CLD and liver transplant recipients, and includes a discussion of the influenza, herpes zoster, hepatitis A, hepatitis B, pneumococcal, human papillomavirus, and COVID-19 vaccines.
Copyright © 2022, Gastro-Hep Communications, Inc.

Entities:  

Keywords:  Vaccines; liver diseases; liver transplantation; vaccine-preventable diseases

Year:  2022        PMID: 35505940      PMCID: PMC9053492     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  89 in total

1.  Influenza vaccination in liver transplant recipients.

Authors:  G Burbach; U Bienzle; K Stark; N Rayes; R Neuhaus; S Serke; H Engelmann; W Künzel; G Türk; P Neuhaus
Journal:  Transplantation       Date:  1999-03-15       Impact factor: 4.939

2.  Double-dose hepatitis B vaccination in cirrhotic patients on a liver transplant waiting list.

Authors:  Patricia R Bonazzi; Telesforo Bacchella; Angela C Freitas; Karina T Osaki; Marta H Lopes; Maristela P Freire; Marcel C C Machado; Edson Abdala
Journal:  Braz J Infect Dis       Date:  2008-08       Impact factor: 1.949

3.  A Double-Blind, Randomized Trial of High-Dose vs Standard-Dose Influenza Vaccine in Adult Solid-Organ Transplant Recipients.

Authors:  Yoichiro Natori; Mika Shiotsuka; Jaclyn Slomovic; Katja Hoschler; Victor Ferreira; Peter Ashton; Coleman Rotstein; Les Lilly; Jeffrey Schiff; Lianne Singer; Atul Humar; Deepali Kumar
Journal:  Clin Infect Dis       Date:  2018-05-17       Impact factor: 9.079

4.  Efficacy of high-dose versus standard-dose influenza vaccine in older adults.

Authors:  Carlos A DiazGranados; Andrew J Dunning; Murray Kimmel; Daniel Kirby; John Treanor; Avi Collins; Richard Pollak; Janet Christoff; John Earl; Victoria Landolfi; Earl Martin; Sanjay Gurunathan; Richard Nathan; David P Greenberg; Nadia G Tornieporth; Michael D Decker; H Keipp Talbot
Journal:  N Engl J Med       Date:  2014-08-14       Impact factor: 91.245

5.  Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients.

Authors:  D Kumar; E R Unger; G Panicker; P Medvedev; L Wilson; A Humar
Journal:  Am J Transplant       Date:  2013-07-09       Impact factor: 8.086

Review 6.  Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C.

Authors:  S Vento
Journal:  J Viral Hepat       Date:  2000-05       Impact factor: 3.728

7.  Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.

Authors:  Anthony L Cunningham; Himal Lal; Martina Kovac; Roman Chlibek; Shinn-Jang Hwang; Javier Díez-Domingo; Olivier Godeaux; Myron J Levin; Janet E McElhaney; Joan Puig-Barberà; Carline Vanden Abeele; Timo Vesikari; Daisuke Watanabe; Toufik Zahaf; Anitta Ahonen; Eugene Athan; Jose F Barba-Gomez; Laura Campora; Ferdinandus de Looze; H Jackson Downey; Wayne Ghesquiere; Iris Gorfinkel; Tiina Korhonen; Edward Leung; Shelly A McNeil; Lidia Oostvogels; Lars Rombo; Jan Smetana; Lily Weckx; Wilfred Yeo; Thomas C Heineman
Journal:  N Engl J Med       Date:  2016-09-15       Impact factor: 91.245

8.  Response to vaccination against hepatitis B virus with a schedule of four 40-μg doses in cirrhotic patients evaluated for liver transplantation: factors associated with a response.

Authors:  I Gutierrez Domingo; J M Pascasio Acevedo; A Alcalde Vargas; A Ramos Cuadra; M T Ferrer Ríos; J M Sousa Martin; M Sayago Mota; A Giráldez Gallego; G Suárez Artacho
Journal:  Transplant Proc       Date:  2012 Jul-Aug       Impact factor: 1.066

9.  Humoral Response to SARS-Cov-2 Vaccination in Liver Transplant Recipients-A Single-Center Experience.

Authors:  Jassin Rashidi-Alavijeh; Alexandra Frey; Moritz Passenberg; Johannes Korth; Jaqueline Zmudzinski; Olympia E Anastasiou; Fuat H Saner; Michael Jahn; Christian M Lange; Katharina Willuweit
Journal:  Vaccines (Basel)       Date:  2021-07-04

10.  Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021.

Authors:  Sara E Oliver; Megan Wallace; Isaac See; Sarah Mbaeyi; Monica Godfrey; Stephen C Hadler; Tara C Jatlaoui; Evelyn Twentyman; Michelle M Hughes; Agam K Rao; Anthony Fiore; John R Su; Karen R Broder; Tom Shimabukuro; Allison Lale; David K Shay; Lauri E Markowitz; Melinda Wharton; Beth P Bell; Oliver Brooks; Veronica McNally; Grace M Lee; H Keipp Talbot; Matthew F Daley
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2022-01-21       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.